Patents by Inventor Friederike Henniges

Friederike Henniges has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the treatment of diabetes
    Patent number: 7122357
    Abstract: The use of physiologically acceptable enzyme mixtures having lipolytic, proteolytica and amylolytic activity, of microbial or animal origin, preferably digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the treatment of diabetes. The invention also relates to the production of pharmaceutical compositions suitable for such treatment. A preferred variant of the invention relates to use of this enzyme mixture having lipolytic, proteolytic and amylolytic activity, especially digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the adjuvant treatment of type I or type II diabetes mellitus.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: October 17, 2006
    Assignee: Solvay Pharmaceuticals GmbH
    Inventors: Suntje Sander-Struckmeier, Claus Rudolf Steinborn, Martin A. Rudmann, Diethard Schwanitz, Friederike Henniges
  • Microbial enzyme mixtures useful to treat digestive disorders
    Publication number: 20040057944
    Abstract: Mixtures of microbial enzymes containing a concentrated Rhizopus delemar lipase, an Aspergillus melleus protease and an Aspergillus oryzae amylase; pharmaceutical preparations containing such mixtures; and the use of such mixtures in methods of treatment and/or prophylaxis of maldigestion, especially maldigestion caused by pancreatic insufficiency, in humans or other mammals.
    Type: Application
    Filed: July 17, 2003
    Publication date: March 25, 2004
    Applicant: Solvay Pharmaceuticals GmbH
    Inventors: Manfred Galle, Peter-Colin Gregory, Andreas Potthoff, Friederike Henniges
  • Method for the treatment of diabetes
    Publication number: 20020061302
    Abstract: The use of physiologically acceptable enzyme mixtures having lipolytic, proteolytica and amylolytic activity, of microbial or animal origin, preferably digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the treatment of diabetes. The invention also relates to the production of pharmaceutical compositions suitable for such treatment. A preferred variant of the invention relates to use of this enzyme mixture having lipolytic, proteolytic and amylolytic activity, especially digestive enzyme mixtures such as pancreatin or digestive enzyme mixtures containing pancreatin, for the adjuvant treatment of type I or type II diabetes mellitus.
    Type: Application
    Filed: September 17, 2001
    Publication date: May 23, 2002
    Inventors: Suntje Sander-Struckmeier, Claus Rudolf Steinborn, Martin A. Rudmann, Diethard Schwanitz, Friederike Henniges